A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer.

Masato OzakaHiroshi IshiiTosiya SatoMakoto UenoMasafumi IkedaKazuhiro UesugiNaohiro SataKouichirou MiyashitaNobumasa MizunoKunihiro TsujiTakuji OkusakaJunji Furuse

Published in: Cancer chemotherapy and pharmacology (2018)

This is the first prospective study of modified FOLFIRINOX in Asia. Modified FOLFIRINOX in this study has an improved safety profile with maintained efficacy in MPC without prophylactic pegfilgrastim.

Keyphrases

locally advanced
phase ii study
rectal cancer
squamous cell carcinoma
radiation therapy
open label
clinical trial
randomized controlled trial
chemotherapy induced
study protocol